IMMUNOMODULATION BY LONGOVITAL IN PATIENTS WITH RECURRENT APHTHOUS ULCERATION

被引:16
|
作者
PEDERSEN, A
KLAUSEN, B
HOUGEN, HP
RYDER, L
WINTHER, K
机构
[1] UNIV COPENHAGEN,BARTHOLIN INST,DK-1168 COPENHAGEN,DENMARK
[2] UNIV COPENHAGEN,INST FORENS MED,DK-1168 COPENHAGEN,DENMARK
[3] ROYAL DENT COLL,DEPT MICROBIOL,DK-2100 COPENHAGEN,DENMARK
[4] FREDERIKSBERG UNIV HOSP,DK-2000 COPENHAGEN,DENMARK
[5] UNIV HOSP COPENHAGEN,RIGSHOSP,DEPT CLIN IMMUNOL,DK-2200 COPENHAGEN N,DENMARK
[6] HVIDOVRE UNIV HOSP,DEPT CLIN CHEM,DK-2650 HVIDOVRE,DENMARK
关键词
aphthae; herbs; immunomodulation; LongoVital; mouth; diseases; natural killer cells; oral; T–lymphocytes; ulceration; vitamins;
D O I
10.1111/j.1600-0714.1990.tb00863.x
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
LongoVital (LV) (DK. Reg. No. 5178/75) is a herbal based tablet enriched with recommended doses of vitamins. Peripheral lymphocyte subsets: T‐helper/CD4 (OKT4 +) and T‐suppressor/cytotoxic/CD8 (OKT8 +) were studied quantitatively in 31 otherwise healthy patients with minor recurrent aphthous ulceration (RAU) during 6 months' daily LV intake in a double‐blind, randomized, crossover 1‐year study. Fourteen had had LV during the first 6 months (GrA) and 17 LV during the latter 6 months (GrB). OKT4 + percentages increased significantly during the LV period in both groups (P <0.05). OKT8+ percentages increased in both groups, however, only significantly in GrA (p <0.05). It is concluded that LV acts as an immunostimulator in patients with RAU and that the increase in T‐lymphocyte subsets may account for the previously reported benefit of LV in RAU prevention. Copyright © 1990, Wiley Blackwell. All rights reserved
引用
收藏
页码:376 / 380
页数:5
相关论文
共 50 条
  • [1] LONGOVITAL IN THE PREVENTION OF RECURRENT APHTHOUS ULCERATION
    PEDERSEN, A
    HOUGEN, HP
    KLAUSEN, B
    WINTHER, K
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 1990, 19 (08) : 371 - 375
  • [2] RECURRENT APHTHOUS ULCERATION - PREVENTION AND LYMPHOCYTE CHANGES BY LONGOVITAL
    PEDERSEN, A
    HOUGEN, HP
    KLAUSEN, B
    RYDER, L
    JOURNAL OF DENTAL RESEARCH, 1990, 69 : 165 - 165
  • [3] Norwegian LongoVital® and recurrent aphthous ulceration:: a randomized, double-blind, placebo-controlled study
    Kolseth, I
    Herlofson, BB
    Pedersen, A
    ORAL DISEASES, 2005, 11 (06) : 374 - 378
  • [4] RECURRENT APHTHOUS ULCERATION
    FENTON, DA
    YOUNG, ER
    WILKINSON, JD
    BRITISH MEDICAL JOURNAL, 1983, 286 (6370): : 1062 - 1062
  • [5] Salivary immunoglobulin A in patients with Recurrent Aphthous Ulceration
    Pakfetrat A.
    Falaki F.
    Sankian M.
    Abbaszadeh H.
    Journal of Applied Sciences, 2010, 10 (23) : 3117 - 3121
  • [6] Treatments for recurrent aphthous ulceration
    Derek Richards
    Evidence-Based Dentistry, 2000, 2 (4) : 110 - 110
  • [7] RECURRENT APHTHOUS ULCERATION + AUTOIMMUNITY
    LEHNER, T
    LANCET, 1964, 2 (737): : 1154 - &
  • [8] JEJUNAL MUCOSAL ABNORMALITIES IN PATIENTS WITH RECURRENT APHTHOUS ULCERATION
    FERGUSON, R
    BASU, MK
    ASQUITH, P
    COOKE, WT
    BRITISH MEDICAL JOURNAL, 1976, 1 (6000): : 11 - 13
  • [9] Prevalence of recurrent aphthous ulceration in Jordanian dental patients
    Safadi R.A.
    BMC Oral Health, 9 (1)
  • [10] INCIDENCE OF HLA ANTIGENS IN PATIENTS WITH RECURRENT APHTHOUS ULCERATION
    WALKER, DM
    SLADE, M
    ALLAN, C
    DOLBY, AE
    JOURNAL OF DENTAL RESEARCH, 1974, 53 (05) : 1047 - 1047